Position in INCY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,702,121
+$661,525 QoQ
Shares Held
50,301
-6.1% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#217
of 854 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 30%
Shared 0%
None 70%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. INCY ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,464 | $22,736,762 | |
| 2 | RPRX |
Royalty Pharma plc
|
337,298 | $18,912,298 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,471 | $17,619,509 | |
| 4 | EXEL |
Exelixis, Inc.
|
303,042 | $16,488,515 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
34,607 | $10,938,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
125,946 | $9,857,793 | |
| 7 | CELC |
Celcuity Inc.
|
71,445 | $7,474,575 | |
| 8 | INCY |
Incyte Corp
This page
|
50,301 | $5,702,121 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,702,121 | 50,301 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,040,596 | 53,555 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,901,757 | 49,628 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,966,394 | 46,768 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $2,347,202 | 34,467 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,744,990 | 28,819 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,392,865 | 20,166 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $382,322 | 5,784 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $446,769 | 7,370 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $373,096 | 6,549 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $515,191 | 8,205 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $483,303 | 8,366 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $479,200 | 7,698 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $483,124 | 6,685 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $559,589 | 6,967 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $545,648 | 8,188 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $345,055 | 4,542 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $267,010 | 3,362 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $141,001 | 1,921 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $46,220 | 672 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $43,747 | 520 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $33,401 | 411 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $84,283 | 969 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $184,774 | 2,059 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $71,427 | 687 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $298,485 | 4,076 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||